Sparrow BioAcoustics today announced the closing of a $10 million financing round led by Killick Capital and Klister Credit, with participation from Pelorus VC, 98827 Newfoundland & Labrador Inc., and Brinex Capital.

ST. JOHN’S, NL, Oct. 29, 2025 – The new investment supports Sparrow’s next phase of growth as hospitals across North America adopt its FDA-cleared Stethophone platform, which is the world’s first cardiac AI platform delivering bioacoustic detection of structural and rhythmic heart anomalies directly through a smartphone.

“This round ensures we can scale responsibly through this critical phase, supporting hospitals and patients with the same focus on quality and outcomes that brought us here,” said Mark Opauszky, CEO of Sparrow BioAcoustics. “It’s about maintaining the momentum we’ve built while continuing to deliver real clinical value where it’s needed most.”

A recent study published in the International Journal of Medical Science and Innovation Research examined the use and clinical accuracy of Sparrow’s Stethophone AI at the University of Washington Medical Center, finding it to be highly accurate in the detection of valvular disease and atrial fibrillation. The authors noted “the system’s AI potential as a mechanism to revolutionize cardiac screening by employing widely available smartphone technology, ensuring broader access to high-quality cardiovascular assessment across diverse healthcare settings,” and highlighted that “improved murmur detection represents a strategic opportunity: earlier identification can lead to increased utilization of confirmatory testing and timely interventions.”

Stethophone is currently being evaluated at several major clinical sites in the United States and Canada.

“In the past year, about 40,000 patients and practitioners have used Stethophone, uncovering thousands of cardiac anomalies that might otherwise have gone unnoticed until later stages of disease,” said Dr. Yaroslav Shpak, Chief Medical Officer and co-founder of Sparrow BioAcoustics. “The demand for practical, scalable screening for conditions such as aortic stenosis continues to grow rapidly, and the feedback from clinicians and patients has been overwhelmingly positive.”

Sparrow has just presented additional updates at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco (October 24–27) and is going to bring Stethophone to the upcoming American Heart Association Scientific Sessions in New Orleans (November 7–10).

About Sparrow BioAcoustics:
Sparrow BioAcoustics is a Canadian medical technology company pioneering AI Phonoscopy, the digital examination of heart sounds using artificial intelligence. Its flagship product, Stethophone, transforms ordinary smartphones into medical-grade cardiac assessment tools capable of detecting murmurs and other signs of heart disease without external hardware. By combining clinical accuracy with universal accessibility, Sparrow aims to close the gap in early cardiac detection and empower clinicians and individuals with actionable insights that improve outcomes and reduce the burden of undiagnosed heart disease.

https://sparrowbioacoustics.com

SOURCE Sparrow BioAcoustics Inc.

Establishes Defense-Grade Digital Backbone to Accelerate Warfighter Capability

WASHINGTON, Oct. 29, 2025 — X-Bow Systems Inc (X-Bow), the leading non-traditional producer of advanced manufactured solid rocket motors (SRMs) and defense technologies, announced today an agreement that establishes the company as the first customer to adopt defense-grade artificial intelligence (AI) capabilities within the Astris AI Factory, a secure, end-to-end AI platform from Astris AI, a Lockheed Martin company.

This move is designed to accelerate X-Bow’s ability to meet urgent national security production demands by establishing a trusted digital backbone for its factory operations.

Why It Matters: Faster, Affordable Rockets

This is about applying defense-grade AI to X-Bow’s most sensitive, mission-critical functions—from secure data governance to factory control. This shift directly enables affordable and faster delivery of tactical rocket motors to the warfighter.

• Defense Focus: X-Bow is establishing an accredited digital environment with its first application being a secure AI agent. This initial governance step is critical to rapidly scaling affordable production for U.S. missile and hypersonics programs by proving the platform’s security for all proprietary Advanced Manufactured Solid Propellant (AMSP) processes.
• Security & IP: Using the Astris AI Factory, which is proven in classified environments, allows X-Bow to handle its core manufacturing IP with defense-grade security, ensuring data integrity from design to deployment.
• Manufacturing Control: The platform’s strategic operational focus is on advanced manufacturing control, leveraging Astris AI Factory’s generative AI and MLOps framework to free up engineering time and improve process control, enabling rapid, reliable iterations essential for defense production.
• Scale & Affordability: The agreement paves the way for X-Bow to rapidly extend this accredited platform across its manufacturing enterprise, enabling real-time production execution and higher throughput for tactical and large-scale rocket motors.

The Tech Stack

The platform integrates the latest AI enterprise software to operationalize sophisticated models.

• This framework allows X-Bow’s custom AI tools to securely retrieve and analyze proprietary technical data in real-time while drawing on multiple large language models for process optimization and digital twin fidelity.
• This architecture is designed to simplify and accelerate the accreditation process, a huge factor for defense suppliers operating on government programs.

The Takeaway

“This customer agreement dramatically improves our ability to secure the necessary accreditation to scale up manufacturing,” said Jason Hundley, Founder and CEO of X-Bow Systems. “This secure, accredited digital backbone is a game-changer for data governance and production integrity, allowing us to focus our engineering resources on delivering rapid, affordable solid rocket motors for our customers.”

“This collaboration marks a defining moment in bringing trusted and reliable AI directly to mission-critical environments,” said James Droskoski, CRO, Astris AI. “By integrating the Astris AI Factory platform into X-Bow’s advanced manufacturing operations, we’re helping deliver a secure, data-driven foundation that accelerates production, strengthens supply chain resilience, and upholds the highest standards of national security. Together, we’re proving that AI can transform both speed and affordability for critical systems that protect our nation.”

About X-Bow Systems

X-Bow Systems is disrupting the aerospace industry with innovative and cost-effective advanced manufactured energetics for the solid rocket motor and launch vehicle market. X-Bow is also designing and building a suite of modular solid rocket motors and small launch vehicles for both orbital and suborbital launch services. X-Bow is led by CEO Jason Hundley, Chairman Mark Kaufman, CTO Max Vozoff, CRO Maureen Gannon, General Counsel John Leary, COO Mike Bender and a growing team of seasoned industry veterans and new space entrepreneurs. X-Bow is a dual-use technology company with investment from: Crosslink Capital, Razor’s Edge Ventures, Balerion Space Ventures, Boeing, Arkenstone Capital, The Capital Factory, Upsher Management Company, Event Horizon Capital, and Lockheed Martin Ventures. Headquartered in Albuquerque, New Mexico, X-Bow has additional presence in California, Alabama, Colorado, Texas, Utah, Maryland and Washington, DC. For more information visit XBowSystems.com.

About Astris AI

Astris AI, a Lockheed Martin company, delivers secure and scalable AI solutions across the defense industrial base and high-assurance commercial industries. Built for mission-critical environments, the Astris AI Factory enables organizations to develop, deploy, and govern generative AI and machine learning systems with full data control, modular open-source flexibility, and defense-grade security. With deep roots in innovation, Astris AI is accelerating digital modernization across aerospace, manufacturing, energy, and national security missions. Visit AstrisAI.com to learn more.

SOURCE X-Bow Systems

The annual list highlights the private equity firms, venture capital firms with track records of
backing founder-led companies.

LOS ANGELES, Oct. 29, 2025 — Trousdale Ventures, an investment firm backing passionate entrepreneurs working to solve some of the world’s most complex challenges, is proud to announce its recognition on the Inc.Founder-Friendly Investors list, honoring the private equity firms, venture capital firms, and lenders with a track record of backing founder-led companies.

The prestigious list celebrates investors who believe in backing founder-led businesses and helping them thrive. All companies on the list have successful track records of collaboration and remaining actively involved with the businesses they invest in.

“Raising capital is no small feat for today’s entrepreneurs. That’s why discovering investors who offer more than just financial backing—those who bring mentorship, resources, and a true spirit of partnership to your growth journey—is both rare and invaluable,” says Bonny Ghosh, editorial director at Inc. “The 2025 Founder-Friendly Investors are collaborators and dedicated to helping their portfolio companies succeed.”

“At Trousdale, being founder-friendly is core to our operating philosophy,” said Phillip Sarofim, Founding Partner and CEO of Trousdale Ventures. “As entrepreneurs, operators, and investors, we bring a multidimensional perspective to every partnership. Our support goes beyond capital, offering hands-on operational guidance, access to industry-shaping networks, and a commitment to help founders scale bold ideas into enduring, impactful companies.”

Trousdale Ventures has become a trusted ally to visionary entrepreneurs pushing the boundaries of what’s possible. The firm’s portfolio spans sectors like deep tech, mobility, aerospace and climate tech, each selected for its world-changing potential. Standout portfolio companies include CesiumAstro, which is redefining space-based connectivity with scalable software-defined communication systems and Venus Aerospace, a leader in hypersonic propulsion. Other portfolio companies include Meyers Manx, Our Next Energy (ONE), Starfish Space, HavocAI, Coreshell Technologies, Impulse Space, Ecovative, Lemon Perfect, Solugen, and more.

Trousdale’s commitment to building “forever companies” is evident across its investments, backing bold founders with resilient leadership. Trousdale counts over 200 companies comprising its portfolio, helping secure key government contracts, scale advanced manufacturing and achieve first-of-their-kind technical milestones.

To compile the list, Inc. went straight to the source: entrepreneurs who have sold to private equity and venture capital firms. Founders filled out a questionnaire about their experiences partnering with private equity, venture capital, and debt firms and shared data on how their companies have grown during these partnerships.

For more information or to view the complete list of honorees, visit https://www.inc.com/founder-friendly-investors.

About Trousdale Ventures:
Led by Founding Partner and CEO Phillip Sarofim, Trousdale Ventures is an investment firm dedicated to backing passionate entrepreneurs who are working to solve some of the world’s most complex challenges. With a focus on deep tech, aerospace, mobility, and climate tech, Trousdale goes beyond capital, offering hands-on operational support, strategic guidance, and an expansive network to help companies scale.

Media Contact: [email protected] 

SOURCE Trousdale Ventures

In a funding round led by Yonder Ventures, Circadian Ventures, and Motivate Ventures, VeroSkills is scaling its AI staffing engine that delivers 48-hour placements and 2–3x higher retention for employers

BIRMINGHAM, Ala., Oct. 29, 2025 — VeroSkills – the AI hiring platform focused on solving the $1 trillion blue-collar labor shortage crisis – today announced the close of a $5.3 million funding round led by Yonder Ventures, along with Circadian Ventures and Motivate Ventures, with participation from Colchuck and Tony Summerville, the founder of Fleetio. The funding allows VeroSkills to accelerate its rapid growth – the firm contracted $15 million in annual recurring revenue in the past six weeks based on its ability to connect employers with millions of pre-screened, ready-to-work candidates from immigrant, refugee, and underserved communities.

For every five workers who retire from blue-collar sectors, only two replace them, creating millions of unfilled jobs. The manufacturing industry alone currently has hundreds of thousands of positions already vacant – a shortfall projected to swell to many millions by the end of the decade.

“What staffing and recruitment agencies do in weeks and months, we do in days and hours, thanks to our AI-driven platform,” said Daniel Walsh, CEO and Founder of VeroSkills. “Given the severity of the labor crisis, there’s no time to waste. There are millions of excellent workers being overlooked by traditional recruiting methods, and VeroSkills has created an effective, first-of-its-kind platform that allows companies to confidently employ them. We’re built to infinitely scale, and I’m proud to work with our investors to reach our potential.”

VeroSkills’ workforce offers employers clear advantages in retention and reliability. Ninety-three percent of employers report retention rates two to three times higher among VeroSkills hires. All workers are fully authorized to work in the U.S., EU, or Canada from day one, streamlining onboarding and reducing administrative hurdles.

“VeroSkills represents the next generation of AI-first labor marketplaces capable of serving the long tail of small and medium-sized businesses that account for 46% of hiring in the United States. What wasn’t economically viable before, efficiently staffing these businesses at scale while interviewing candidates in 52 languages, is now possible with AI, unlocking millions of workers and employers who were previously invisible to each other,” said Colin Gardiner, Founding Partner at Yonder Ventures.

“Under Daniel’s leadership, the team is consistently achieving standout results through innovation in an industry historically slow to evolve. Their commitment to building sustainable employment solutions in labor-limited markets continues to resonate with all stakeholders,” said Mike Dowdle, Founding Partner at Circadian Ventures.

“VeroSkills has cracked the code on what traditional staffing agencies have struggled with for decades: speed, scale, and retention. Their AI-powered approach delivers measurable results in an industry ripe for disruption, and we’re excited to support their rapid growth trajectory,” said Lauren Deluca, Founding and Managing Partner at Motivate Ventures.

About VeroSkills
VeroSkills is an AI-powered staffing platform connecting blue-collar businesses to pre-screened, ready-to-work candidates from immigrant, refugee, and underserved communities. The company delivers 48-hour placements through proprietary AI screening technology and access to millions of people authorized to work in the U.S., EU, or Canada. Learn more at veroskills.com.

About Yonder Ventures
Yonder is an early-stage VC firm focused on investing in AI-native marketplaces that build new economies. The fund is led by Colin Gardiner, a marketplace geek and 3x marketplace operator who helped scale Outdoorsy to $3B+ in revenue. He is a go-to marketplace expert, having worked with 100+ marketplaces, and writes Take Rate, the world’s largest marketplace newsletter. For further information, visit https://www.yonder.vc/

About Circadian Ventures 
Circadian Ventures is a venture capital firm investing in early-stage tech and tech-enabled businesses. Circadian Ventures actively partners with exceptional entrepreneurs to build enduring businesses. Based in Atlanta, the firm has investments in various sectors across the United States. For further information, visit www.circadian.vc

About Motivate Ventures
Motivate is a Chicago-based VC firm with a deep commitment to providing institutional capital and support at the earliest stages. Launched by entrepreneurs with backgrounds in fintech and enterprise software, the Motivate team invests in pre-seed and seed stage companies across the US and Canada. The singular vision is to find and empower the most promising founders building tomorrow’s greatest companies. For further information, visit https://motivate.vc/

SOURCE VeroSkills

NEW YORK, Oct. 29, 2025 — Iris Ventures, the global investment firm behind some of beauty and wellness’s most trailblazing and transformative brands, has made a multimillion-dollar minority investment in Goddess Maintenance Co., a biotech beauty brand pioneering science-backed innovations for lasting hair health and protection.

Founded by Denise Russell, Edward Connaghan, Lauren Vesler and Manda Mason, Goddess Maintenance Co. is redefining professional hair care through a proprietary new category called “bioprotection.” Russell and Connaghan, both early operators behind breakthrough hair care brands Olaplex and K18, joined forces with sisters Vesler and Mason to create a next-generation professional system grounded in biotechnology.

At the heart of the brand is the Goddess Molecule, developed in partnership with biomaterials innovation leader, Bolt. Inspired by the structure of spider silk, celebrated for its extraordinary strength and flexibility, the molecule forms scaffold-like chains that wrap around each strand to defend hair against environmental and chemical damage. The dual-action molecule also penetrates the cuticle to reinforce the structure at the hair’s cortex. The result is a breakthrough chain mail-style protective effect that strengthens from within, reduces styling time, improves manageability and extends salon finishes.

Following the launch of its breakthrough first product BioTech Blowout™ Leave-In Restorative Mask earlier this year, Goddess Maintenance Co. has swiftly built a footprint in more than 100 countries, reflecting the brand’s momentum and the growing global demand for innovation in hair care.

“Partnering with Iris felt like a natural next step,” said Lauren Vesler, CEO of Goddess Maintenance Co. “While we weren’t actively seeking investment, their deep understanding of the beauty industry, unwavering commitment to innovation and belief in our mission to pioneer bioprotection in hair care made them the ideal partner to help us scale our vision globally.”

Iris Ventures’ portfolio includes Maurten (sports nutrition), Olistic (hair health), Healf (well-being retail platform) and Superlativa (women’s supplements), among others. The firm is currently launching its second fund, targeting €200 million, to continue investing in founder-led, purpose-driven consumer brands.

Montse Suarez, founder and managing partner at Iris Ventures, said: “Goddess is at the forefront of science-led beauty, pioneering the bioprotection category and redefining what’s possible in professional hair care. With its proprietary molecule, deep stylist-first approach and global ambition, Goddess is delivering a true breakthrough that bridges the gap between repair and maintenance, transforming how we think about long-term hair health. It’s rare to see a brand so deeply rooted in science yet so emotionally resonant with both professionals and consumers alike.”

“Goddess exemplifies the kind of boundary-breaking innovation we look for: world-class science, a clear mission and a brand built to resonate globally,” said Marc Calzada, Investor, Iris Ventures. “Their leadership team has the ambition and capability to lead the next evolution in professional beauty.”

The new funding will accelerate the brand’s product development pipeline, expand its professional salon partnerships and advance its international expansion strategy.

About Goddess Maintenance Co.
Goddess Maintenance Co. is a biotech beauty company dedicated to advancing the long-term health and vitality of hair through a new category: bioprotection. Built on patented technology developed with Bolt, Goddess Maintenance products strengthen and protect hair from the inside out, merging science and beauty for the professional community worldwide.

About Iris Ventures
Iris Ventures is a global consumer growth investment firm partnering with visionary, founder-led brands across beauty, wellness and lifestyle. Guided by the mission to invest in companies that improve well-being and quality of life, Iris Ventures brings deep industry expertise, strategic resources and a global network to help brands scale sustainably.

MEDIA CONTACT:
[email protected]

SOURCE Goddess Maintenance Co.

The modern homecare brand continues redefining the category through fine-fragrance, design, and craftsmanship

LOS ANGELES, Oct. 29, 2025 — Homecourt, the award-winning home and personal fragrance brand founded by Courteney Cox, has raised an $8 million Series A round led by CULT Capital. The funding will accelerate brand awareness, expand the team, and strengthen infrastructure to support continued growth.

Homecourt has quickly built a cult following since its 2022 launch, expanding from homecare into new categories including body and laundry, and widening distribution channels from DTC to 300+ doors across the US including Nordstrom, Blue Mercury and Revolve. A 4x Allure Best of Beauty Winner, Homecourt has also been recognized by Fast Company as one of the “World’s Most Innovative Companies” and by Inc. as “Best in Business.”

“With less than 5 full-time employees, we’ve doubled the business every year and built a cult brand that’s defining a new category in the beauty industry,” said Sarah Jahnke, Co-founder and CEO.  “This fundraise gives us the resources to accelerate our impact and scale our category leadership.”

“I am unbelievably excited to take this business to the next level. Homecourt is my greatest passion, and bringing on a strategic investment partner like CULT means we can become the global household name I know we can be,” shares Courteney Cox, Founder of Homecourt.

CULT Capital brings deep expertise in scaling consumer brands, and a proven track record in beauty with a portfolio that includes Supergoop!, LAWLESS Beauty, and Act+Acre. With the close of its second fund, CULT continues its focus on backing the rare and remarkable few brands redefining their categories. Known for its highly selective investment approach, CULT reviews hundreds of companies annually but invests in only a handful, underscoring Homecourt’s standout position and extraordinary potential in the beauty industry.

“CULT is thrilled to welcome Homecourt to our family of cult brands,” said Sarah Woelfel, Co-Founder and Partner at CULT Capital. “We see in Courteney an authentic founder with a clear mission to elevate consumers’ homes in a meaningful way, and in Sarah an exceptional CEO who brings the experience and resources to bring that vision to life. Together, they make a powerful team. We’re excited to partner with Courteney, Sarah and existing investors to scale Homecourt through a best-in-class growth strategy, supported by CULT’s deep expertise, operational discipline, and passion for building enduring brands.“

Cult Capital is Homecourt’s only institutional investor. Previously, Homecourt raised money exclusively from friends and family, spearheaded by Bilal Mekkaoui and Ryan Nelson (co-founders of venture studio Jobi Brands).  Homecourt is proud to be majority women-owned and led.

About Homecourt:
Homecourt is a category-defining luxury fragrance and homecare brand founded by Courteney Cox and beauty industry veteran Sarah Jahnke. Bringing beauty, fine-fragrance, and elevated design into everyday rituals, the brand has quickly become a leader in the premium lifestyle and home fragrance space, known for its best-selling cleaning, body, and laundry collections. The brand’s award-winning, non-toxic collection of home, body, and laundry products is available at homecourt.co, Amazon, Nordstrom, Bluemercury, and select independent boutiques.

About CULT Capital:
Founded by John Kenney and Sarah Woelfel in 2015, CULT Capital’s investment philosophy is grounded in identifying and partnering with companies led by passionate entrepreneurs who offer distinctive products with proven product-market fit. The firm is committed to providing capital and strategic support to help emerging consumer brands achieve cult status. Armed with deep expertise and a genuine passion for brand building, CULT Capital has successfully collaborated with a portfolio of consumer brands, including Supergoop!, LAWLESS Beauty, Act+Acre, Elavi, Subtl Beauty, Luna Daily and Hanni among others.  CULT Capital is investing from its second investment fund.

Media Contact:
[email protected]

SOURCE Homecourt

MINNEAPOLIS, Oct. 29, 2025 — VentureMed Group, Inc., a leading medical device company specializing in vessel preparation and access management technologies for the treatment of peripheral arterial disease (PAD) and arteriovenous fistulas and grafts (AVF, AVG), today announced the closing of a $28 million Series C financing round led by S3 Ventures, and joined by existing investors including Endeavour Vision.

“As we enter our next phase, we are grateful for the continued support of our existing investors and excited to welcome new partners to the syndicate,” said Denis Harrington, President and CEO of VentureMed. “This significant financing underscores investor confidence in the FLEX Vessel Prep™ System and our mission to strengthen VentureMed’s position in global vascular care.”

In addition to expanded commercial infrastructure, the funding will also advance VentureMed’s clinical program and support new product development, including new applications in adjacent vascular settings.

“VentureMed is addressing one of the most persistent challenges in vascular access with a technology that is both elegant and transformative,” said Brian R. Smith, Managing Director at S3 Ventures. “Our partnership reflects a shared mission to bring breakthrough treatments to those who need them most.”

Vascular diseases are a growing burden globally, driven by the rise in obesity, diabetes and hypertension. PAD affects more than 20 million people in the U.S. and over 200 million worldwide¹, while stenosis and vessel dysfunction remain major causes of access failure in dialysis patients. FLEX was developed to improve vessel compliance, minimize trauma, and support better long-term outcomes. “Lesion prep is rapidly becoming one of the most important procedures for improving patient outcomes. The FLEX VP system is leading the way in addressing AV Access interventions,” said Dr. Ari Kramer, General Surgeon, Spartanburg Medical Center. “This fundraising is an important milestone as the company advances additional clinical evidence and expanded indications.”

Already FDA 510(k)-cleared, CE Mark-approved, and supported in the U.S. by a dedicated CMS HCPCS code (C1600) with transitional pass-through payment, FLEX is positioned to redefine vessel preparation and potentially expand treatment options worldwide.

“The cycle of re-narrowing and repeat procedures in vascular disease places a significant burden on patients and health systems,” said Alexander Schmitz, Partner at Endeavour Vision. “A technology that reduces the need for reinterventions not only improves outcomes but also aligns with the shift to value-based care. We’re excited to continue supporting VentureMed as it expands access to this important therapy.”

About VentureMed Group & FLEX Vessel Prep™ System
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral arterial disease (PAD) interventions. The company’s flagship technology, the FLEX Vessel Prep™ System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology. Unlike traditional balloon-based approaches that apply static pressure, KEMIC leverages controlled motion and dynamic vessel apposition to create long, precise micro-incisions. This unique mechanism facilitates luminal gain, may enhance drug uptake when used in combination therapy, and may reduce vessel trauma – ultimately lowering the risk of restenosis. For more information, visit www.VentureMedgroup.com.

References: 1. Allison M.A. et al.Circulation. 2023;148:286–296.

Media contact: Tom Michals
[email protected]
+1(763) 951-0280

Logo – https://mma.prnewswire.com/media/658751/VentureMed_Group_Logo.jpg

As wage pressures, regulation, and caregiver shortages strain post-acute providers, Arya is using AI to automate non-clinical administration, freeing resources to focus on care

NEW YORK, Oct. 29, 2025 — Arya Health (Arya), an AI company helping home health and post-acute care providers automate scheduling, compliance, and other administrative operations, announced today its $18.2 million Series A funding. The round was led by ACME Capital, with participation from Ridge Ventures, Twelve Below, executives from OpenAI, and leading post-acute care providers, bringing Arya’s total funding to $25 million.

Post-acute care providers, including home healthcare agencies, hospice providers, and long-term care facilities, are facing unprecedented strain. Rapid regulatory changes, caregiver shortages, and escalating wage pressures are pushing an already margin-constrained industry to the brink. Meanwhile, heavy private equity investment and consolidation call for a renewed focus on operational excellence and thinking beyond the traditional “people-heavy” approach to post-acute care administration.

Arya is building a new AI-native “system of action” that sits alongside the Electronic Medical Record (EMR) to automate the heavy administrative load that burdens front office teams, slows growth, and diverts resources from patient care and caregiver support.

“Post-acute care organizations spend roughly 25 cents of every dollar on non-clinical tasks,” said Kunal Sarda, CEO and co-founder of Arya Health. “That’s time and money that should be going toward caregivers and patients, not process. Arya is flipping that equation by using AI to take on the operational burden so providers can focus on delivering care, not moving patients, caregivers, and data around in their EMR. Our mandate is to make post-acute care administration more scalable, human, and cost-effective at the same time.”

Arya’s AI-powered digital agents automate key post-acute care workflows, including caregiver scheduling, compliance tracking, and hiring pipeline management. Embedded in daily operations, these agents continuously learn and adapt to increase workforce efficiency. Recent innovations include the Onboarding Agent, which reduces time-to-first-staffing by 50% with 70% less administrative effort; the Talent Acquisition Agent, which autonomously recruits and schedules caregivers with 60% less human effort; and the Compliance Agent, which eliminates manual license tracking and deploys in just one week. The company is also preparing to launch an Intake Agent in Q4, designed to accelerate patient start of care and reduce critical back-office bottlenecks.

The new funding will enable Arya to expand its product suite across additional administrative functions and scale hiring to keep pace with market demand. Arya has grown revenue more than 6x in 2025 and is on track for 10x year-over-year growth by year-end.

As part of this next phase, Arya has appointed Melinda Phillips, former CEO of Thrive Skilled Pediatric Care (acquired by Aveanna), to lead its Care@Home Center of Excellence, where she will help scale AI adoption across the home care sector. A veteran operator of one of the nation’s largest post-acute providers, she brings deep industry experience to Arya’s technology-driven team, strengthening the company’s blend of insider expertise and outsider innovation.

“Arya represents exactly the kind of innovation post-acute care needs right now,” said Aike Ho, Partner at ACME Capital. “They’re pairing deep operational expertise with cutting-edge AI to unlock entirely new economics for providers, without sacrificing the humanity at the heart of care.”

To learn more, visit www.aryahealth.ai.

About Arya Health
Arya Health builds AI-powered digital agents that eliminate the administrative burden in post-acute care-so caregivers and coordinators can focus on patients, not processes. Purpose-built for home health, home care, and hospice, Arya integrates with leading EMRs to automate scheduling, compliance, onboarding, and more. By replacing manual office work with intelligent automation, Arya helps agencies cut costs, boost caregiver utilization, and scale efficiently-while keeping humanity at the heart of care.

Media contact:
BAM for Arya Health
[email protected] 

SOURCE Arya Health / BAM

Represents Ericsson’s latest AI investment as Voxel leads transformation from reactive to proactive workplace safety

SAN FRANCISCO, Oct. 29, 2025 — Voxel, the computer vision AI company revolutionizing workplace safety and risk, today announced a strategic investment from Ericsson Ventures, part of the Ericsson Group (NASDAQ: ERIC), a world leader in communications technology, offering hardware, software, and services to enable connectivity. This funding marks the latest significant investment Ericsson has made out of their Artificial Intelligence (AI) program.

Voxel recently completed a $44M Series B funding round, which was led by NewRoad Capital Partners with participation from Eclipse, Rite-Hite, Tokio Marine, MTech, HG Ventures and Whitestone. This round brings the company’s total funding of $64 million to date.

“This investment represents more than capital – it’s a strategic partnership built on shared vision,” said Vernon O’Donnell, CEO of Voxel. “Following our Series B, we’re focused on scaling our impact, and Ericsson brings both the global reach and technical expertise to help us transform workplace safety across industries worldwide.”

Jose Suarez, Head of Ericsson Ventures said, “Ericsson is committed to workplace safety as a core value. Voxel’s platform delivers tangible results, reducing workplace incidents and delivering immediate ROI to customers. We are excited to partner with Voxel to help companies protect their most important assets – their people.”

Voxel is hiring across all business units and offices. Open positions can be found here. To learn more about the solutions Voxel offers, please book time with our team.

About Voxel
Voxel is revolutionizing workplace safety with its AI-powered site visibility platform, designed to help organizations identify and mitigate risks in industrial environments. Using existing cameras, Voxel transforms basic video footage into actionable insights, enabling organizations to proactively make workplaces safer and more effective.

Voxel partners with businesses across industries such as warehousing, manufacturing, distribution, and insurance. By equipping businesses with the tools to identify risks before they happen, Voxel powers safer, more effective work environments.

SOURCE Voxel